血管內(nèi)皮生長(zhǎng)因子121(VEGF121)重組蛋白
Recombinant Vascular Endothelial Growth Factor 121 (VEGF121)
- 編號(hào)RPB851Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量18.2kDa
- 實(shí)際分子量18&17kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Pro28~Arg147 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)6.3
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 960 ¥ 2400 ¥ 4800 ¥ 14400 ¥ 36000
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB851Hu01 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB851Hu02 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB851Hu01 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB851Hu01 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)多克隆抗體 | WB; IHC; ICC; IP. |
PAB851Hu02 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)多克隆抗體 | WB; IHC; ICC; IP. |
LAB851Hu71 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB851Hu22 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu23 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu24 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu25 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu27 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
MAB851Hu21 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)單克隆抗體 | WB; IHC; ICC; IP. |
SEB851Hu | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB851Hu | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
PSB851Hu01 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)抗體對(duì) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSB851Hu01 | 血管內(nèi)皮生長(zhǎng)因子121(VEGF121)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Oncogene | Elevated PLGF contributes to small-cell lung cancer brain metastasis [PubMed: 22797069] |
BMC?Cancer | VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma [Pubmed:29747600] |
JOURNAL OF CLINICAL NEUROSCIENCE | A pediatric case of anaplastic astrocytoma with a gliomatosis cerebri; the growth pattern and changes in serum VEGF-121 levels after bevacizumab treatment [Pubmed: 33222957] |
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE | Associations between VEGF isoforms and impending retinopathy of prematurity [Pubmed: 32737903] |
international journal of oncology | Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma [Pubmed: 32377747] |
留言咨詢